1
|
Oudjedi A, Allali A, Bekli A, Lounis M, Ben Saad H, Boukoufa M. Reported COVID-19 vaccines side effects among Algerian athletes: a comparison between inactivated virus, adenoviral vector, and mRNA COVID-19 vaccines. PHYSICIAN SPORTSMED 2024; 52:134-146. [PMID: 36876437 DOI: 10.1080/00913847.2023.2186691] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Received: 10/29/2022] [Accepted: 02/20/2023] [Indexed: 03/07/2023]
Abstract
OBJECTIVES Many types of COVID19 vaccines are administered globally, yet there is not much evidence regarding their side effects among athletes. This study evaluated the selfreported postvaccination side effects of inactivated virus, adenoviral vector, and mRNA COVID19 vaccines among Algerian athletes. METHODS A cross-sectional survey-based study was carried out in Algeria between March 01 and 4 April 2022. The study used a validated questionnaire with twenty-five multiple-choice items covering the participants' anamnestic characteristics, post-vaccination side effects (their onset and duration), post-vaccination medical care, and risk factors. RESULTS A total of 273 athletes completed the survey. Overall, (54.6%) of the athletes reported at least one local side effect, while (46.9%) reported at least one systemic side effect. These side effects were more prevalent among the adenoviral vector group compared to the inactivated virus and mRNA groups. The most common local side effect was injection site pain (29.9%), while Fever (30.8%) was the most prevalent systemic side effect. The age group of 31-40 years, allergy, previous infection with COVID-19, and the first dose of vaccines were associated with an increased risk of side effects for all groups of COVID-19 vaccines. Logistic regression analysis further revealed that compared to males, the incidence of reported side effects was significantly higher in females (odd ratio (OR) = 1.16; P = 0.015*) only for the adenoviral vector vaccine group. In addition, a significantly higher percentage of athletes group of high dynamic/moderate static or high dynamic /high static components suffered from post-vaccination side effects compared to the group of athletes with high dynamic/low static components (OR = 14.68 and 14.71; P < 0.001, respectively). CONCLUSIONS The adenoviral vector vaccines have the highest rate of side effects, followed by the inactivated virus and mRNA COVID-19 vaccines. COVID‑19 vaccines were well-tolerated among Algerian athletes and there were no reports of serious side effects. Nevertheless, further long-term follow-up study with a larger sample size of athletes (from different types and sports categories) is warranted to establish the long-term safety of the COVID-19 vaccine.
Collapse
Affiliation(s)
- Adda Oudjedi
- Institute of Science and Techniques of Physical and Sports Activities, Department of Physical Education and Sports, University of Oum El Bouaghi, Oum El Bouaghi, Algeria
| | - Abdelghani Allali
- Institute of Science and Techniques of Physical and Sports Activities, Department of Physical Education and Sports, University of Oum El Bouaghi, Oum El Bouaghi, Algeria
| | - Aissa Bekli
- Institute of Physical Education and Sports, Hassiba Ben Bouali University, Chlef, Algeria
| | - Mohamed Lounis
- Department of Agro-Veterinary Science, Faculty of Natural and Life Sciences, University of Ziane Achour, Djelfa, Algeria
| | - Helmi Ben Saad
- University of Sousse, Faculty of Medicine of Sousse, Hospital Farhat HACHED of Sousse, Research Laboratory, Heart Failure, LR12SP09, Sousse, Tunisia
| | - Mohamed Boukoufa
- Institute of physical education and sports, Ibrahim Sultan Cheibout University of Algiers 3, Algiers, Algeria
| |
Collapse
|
2
|
Bruyère O, Martens G, Demonceau C, Urhausen A, Seil R, Leclerc S, Le Garrec S, Le Van P, Edouard P, Tscholl PM, Delvaux F, Toussaint JF, Kaux JF. Impact of COVID-19 Vaccination on Short-Term Perceived Change in Physical Performance among Elite Athletes: An International Survey. Vaccines (Basel) 2023; 11:vaccines11040796. [PMID: 37112708 PMCID: PMC10144569 DOI: 10.3390/vaccines11040796] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 03/09/2023] [Revised: 03/28/2023] [Accepted: 04/01/2023] [Indexed: 04/07/2023] Open
Abstract
COVID-19 vaccination raised concerns about its potential effects on physical performance. To assess the impact of COVID-19 vaccination on the perceived change in physical performance, we conducted an online survey among elite athletes from Belgium, Canada, France and Luxembourg, with questions about socio-demographics, COVID-19 vaccination, perceived impact on physical performance and perceived pressure to get vaccinated. Full vaccination was defined as two doses of mRNA or vector vaccine or a heterologous vaccine scheme. Among 1106 eligible athletes contacted, 306 athletes answered the survey and were included in this study. Of these, 72% perceived no change in their physical performance, 4% an improvement and 24% a negative impact following full COVID-19 vaccination. For 82% of the included athletes, the duration of the negative vaccine reactions was ≤3 days. After adjustment for potential confounding variables, practicing an individual sport, a duration of vaccine reactions longer than 3 days, a high level of vaccine reaction and the perceived pressure to get vaccinated were independently associated with a perceived negative impact on physical performance of more than 3 days after the vaccination. The perceived pressure to get vaccinated appears to be a parameter associated with the negative perceived change in the physical performance and deserves further consideration.
Collapse
Affiliation(s)
- Olivier Bruyère
- WHO Collaborating Centre for Public Health Aspects of Musculo-Skeletal Health and Ageing, Division of Public Health, Epidemiology and Health, Economics, University of Liège, 4000 Liège, Belgium
- Department of Sport and Rehabilitation Sciences, University of Liège, 4000 Liège, Belgium
- Physical Medicine and Sport Traumatology Department, SportS2, FIFA Medical Centre of Excellence, FIMS Collaborative Centre of Sports Medicine, University and University Hospital of Liège, 4000 Liège, Belgium
| | - Géraldine Martens
- Physical Medicine and Sport Traumatology Department, SportS2, FIFA Medical Centre of Excellence, FIMS Collaborative Centre of Sports Medicine, University and University Hospital of Liège, 4000 Liège, Belgium
- Réseau Francophone Olympique de la Recherche en Médecine du Sport (ReFORM) IOC Research Centre for Injury Prevention and Protection of Athlete Health, 4000 Liège, Belgium
- Québec National Institute of Sports (INS Québec), Montréal, QC H1V 3N7, Canada
| | - Céline Demonceau
- WHO Collaborating Centre for Public Health Aspects of Musculo-Skeletal Health and Ageing, Division of Public Health, Epidemiology and Health, Economics, University of Liège, 4000 Liège, Belgium
| | - Axel Urhausen
- Réseau Francophone Olympique de la Recherche en Médecine du Sport (ReFORM) IOC Research Centre for Injury Prevention and Protection of Athlete Health, 4000 Liège, Belgium
- Luxembourg Institute of Research in Orthopedics, Sports Medicine and Science, 1460 Luxembourg, Luxembourg
- Clinique du Sport, Centre Hospitalier de Luxembourg, 1460 Luxembourg, Luxembourg
| | - Romain Seil
- Réseau Francophone Olympique de la Recherche en Médecine du Sport (ReFORM) IOC Research Centre for Injury Prevention and Protection of Athlete Health, 4000 Liège, Belgium
- Luxembourg Institute of Research in Orthopedics, Sports Medicine and Science, 1460 Luxembourg, Luxembourg
- Clinique du Sport, Centre Hospitalier de Luxembourg, 1460 Luxembourg, Luxembourg
- Department of Orthopaedic Surgey, Centre Hospitalier de Luxembourg, 1460 Luxembourg, Luxembourg
| | - Suzanne Leclerc
- Réseau Francophone Olympique de la Recherche en Médecine du Sport (ReFORM) IOC Research Centre for Injury Prevention and Protection of Athlete Health, 4000 Liège, Belgium
- Québec National Institute of Sports (INS Québec), Montréal, QC H1V 3N7, Canada
| | - Sébastien Le Garrec
- Réseau Francophone Olympique de la Recherche en Médecine du Sport (ReFORM) IOC Research Centre for Injury Prevention and Protection of Athlete Health, 4000 Liège, Belgium
- National Institute of Sport, Expertise and Performance (INSEP), 75012 Paris, France
| | - Philippe Le Van
- Réseau Francophone Olympique de la Recherche en Médecine du Sport (ReFORM) IOC Research Centre for Injury Prevention and Protection of Athlete Health, 4000 Liège, Belgium
- National Institute of Sport, Expertise and Performance (INSEP), 75012 Paris, France
| | - Pascal Edouard
- Sports Medicine Unit, Department of Clinical and Exercise Physiology, University Hospital of Saint-Etienne, 42055 Saint-Etienne, France
- Inter-University Laboratory of Human Movement Biology, Université Jean Monnet, Lyon 1, Université Savoie Mont-Blanc, EA 7424, F-42023 Saint-Etienne, France
| | - Philippe M Tscholl
- Réseau Francophone Olympique de la Recherche en Médecine du Sport (ReFORM) IOC Research Centre for Injury Prevention and Protection of Athlete Health, 4000 Liège, Belgium
- Department of Orthopaedic Surgery and Traumatology, Geneva University Hospitals, CH-1211 Geneva, Switzerland
| | - François Delvaux
- Department of Sport and Rehabilitation Sciences, University of Liège, 4000 Liège, Belgium
- Physical Medicine and Sport Traumatology Department, SportS2, FIFA Medical Centre of Excellence, FIMS Collaborative Centre of Sports Medicine, University and University Hospital of Liège, 4000 Liège, Belgium
- Réseau Francophone Olympique de la Recherche en Médecine du Sport (ReFORM) IOC Research Centre for Injury Prevention and Protection of Athlete Health, 4000 Liège, Belgium
| | - Jean-François Toussaint
- Réseau Francophone Olympique de la Recherche en Médecine du Sport (ReFORM) IOC Research Centre for Injury Prevention and Protection of Athlete Health, 4000 Liège, Belgium
- URP 7329-IRMES (Institute for Research in Medicine and Epidemiology of Sport), National Institute of Sport, Expertise and Performance (INSEP), 75012 Paris, France
| | - Jean-François Kaux
- Department of Sport and Rehabilitation Sciences, University of Liège, 4000 Liège, Belgium
- Physical Medicine and Sport Traumatology Department, SportS2, FIFA Medical Centre of Excellence, FIMS Collaborative Centre of Sports Medicine, University and University Hospital of Liège, 4000 Liège, Belgium
- Réseau Francophone Olympique de la Recherche en Médecine du Sport (ReFORM) IOC Research Centre for Injury Prevention and Protection of Athlete Health, 4000 Liège, Belgium
| |
Collapse
|
3
|
Narducci DM, Diamond AB, Bernhardt DT, Roberts WO. COVID Vaccination in Athletes and Updated Interim Guidance on the Preparticipation Physical Examination During the SARS-Cov-2 Pandemic. Clin J Sport Med 2022; 32:e1-e6. [PMID: 34723865 DOI: 10.1097/jsm.0000000000000981] [Citation(s) in RCA: 3] [Impact Index Per Article: 1.5] [Reference Citation Analysis] [Abstract] [MESH Headings] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Received: 08/11/2021] [Accepted: 08/24/2021] [Indexed: 02/02/2023]
Abstract
ABSTRACT The American Medical Society for Sports Medicine (AMSSM) convened an expert panel to address the current evidence, knowledge gaps, and recommendations surrounding the COVID vaccination in athletes during the SARS-CoV-2 pandemic. The group held a series of meetings beginning in July 2021 and reviewed the available literature while using an iterative process and expert consensus to finalize this guidance statement. This document is intended to provide clinicians with suggestions on how to incorporate the COVID vaccination during the preparticipation physical examination for athletes in all levels of training and competition. The statement is not intended to address treatment, infection control principles, safety, ethical discussion, or public health issues related to SARS-CoV-2. The AMSSM task force acknowledges the clinical uncertainty, evolving public health objectives, and the limited data currently available to create this guidance statement.
Collapse
Affiliation(s)
- Dusty Marie Narducci
- Departments of Family Medicine and Orthopedics, University of South Florida, Tampa, Florida
| | - Alex B Diamond
- Departments of Pediatrics and Orthopedics and Rehabilitation, University of Wisconsin School of Medicine and Public Health, Madison, Wisconsin; and
| | - David T Bernhardt
- Departments of Pediatrics and Orthopedics and Rehabilitation, University of Wisconsin School of Medicine and Public Health, Madison, Wisconsin; and
| | - William O Roberts
- Department of Family Medicine and Community Health, University of Minnesota Medical School, Minneapolis, Minnesota
| |
Collapse
|
4
|
Narducci DM, Diamond AB, Bernhardt DT, Roberts WO. COVID Vaccination in Athletes & Updated Interim Guidance on the Preparticipation Physical Examination during the SARS-CoV-2 Pandemic. Curr Sports Med Rep 2021; 20:608-613. [PMID: 34752435 DOI: 10.1249/jsr.0000000000000912] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/21/2022]
Abstract
ABSTRACT The American Medical Society for Sports Medicine (AMSSM) convened an expert panel to address the current evidence, knowledge gaps, and recommendations surrounding the COVID vaccination in athletes during the SARS-CoV-2 pandemic. The group held a series of meetings beginning in July 2021 and reviewed the available literature while using an iterative process and expert consensus to finalize this guidance statement. This document is intended to provide clinicians with suggestions on how to incorporate the COVID vaccination during the preparticipation physical examination for athletes in all levels of training and competition. The statement is not intended to address treatment, infection control principles, safety, ethical discussion, or public health issues related to SARS-CoV-2. The AMSSM task force acknowledges the clinical uncertainty, evolving public health objectives, and the limited data currently available to create this guidance statement.
Collapse
Affiliation(s)
- Dusty Marie Narducci
- Department of Family Medicine and Orthopedics University of South Florida Health, Tampa, FL
| | - Alex B Diamond
- Department of Orthopaedic Surgery and Pediatrics, Vanderbilt University Medical Center, Nashville, TN
| | - David T Bernhardt
- Department of Pediatrics and Orthopedics and Rehabilitation, University of Wisconsin School of Medicine and Public Health, Madison, WI
| | - William O Roberts
- Department of Family Medicine and Community Health, University of Minnesota Medical School, Minneapolis, MN
| |
Collapse
|